Celularity Inc. (CELU)Healthcare | Biotechnology | Florham Park, United States | NasdaqCM
1.42 USD
-0.05
(-3.401%) ⇩
(Oct. 13, 2026, 4 p.m.
EDT)
|
Hot Take ↕ | Oct. 10, 2026, 2:38 a.m. EDT
The investment case here is fundamentally broken by a deteriorating business and existential regulatory threats. The company is hemorrhaging cash with negative operating margins and a massive debt load relative to its tiny market cap. More critically, the stock faces immediate delisting risks from Nasdaq due to non-compliance with listing rules, creating a severe liquidity and survival crisis. While the price has recently rallied on insider lending and narrower losses, this is a classic 'death spiral' rally rather than a recovery. The options market confirms this fear, with heavy put buying establishing a wall at $2.50 that suggests the smart money expects the stock to fall further. With no dividend to offset the risk and a trajectory of nearly 98% destruction over six years, this is a speculative trap disguised as a turnaround story. |
| Model | MAE |
|---|---|
| AutoARIMA ✓ | 0.386686 |
| AutoETS | 0.386686 |
| MSTL | 0.389468 |
| AutoTheta | 0.436638 |
Forecast horizon: 45 days | Selected: AutoARIMA
| Forecast Reliability | |
|---|---|
| Score | 23% |
| H-stat | 29.12 |
| Ljung-Box p | 0.000 |
| Jarque-Bera p | 0.114 |
| Excess Kurtosis | -1.50 |
| Attribute | Value |
|---|---|
| Sector | Healthcare |
| Revenue per Share | 0.703 |
| Market Cap | 46,078,668 |
| Forward P/E | -2.49 |
| Beta | 0.78 |
| Previous Name | GX Acquisition Corp. |
| Website | https://www.celularity.com |
As of Oct. 10, 2026, 2:38 a.m. EDT: Speculators are heavily positioning for downside protection rather than upside participation. Put open interest significantly exceeds call open interest across all expirations, with the highest concentration of strikes at $2.50. This 'bear put' skew suggests traders expect the stock to struggle to break above $2.00, viewing the current price as vulnerable to further declines despite recent volatility.
| Attribute | Value |
|---|---|
| 52 Week Change | -0.3524229 |
| Address1 | 170 Park Avenue |
| All Time High | 134.0 |
| All Time Low | 0.56 |
| Ask | 2.03 |
| Ask Size | 2 |
| Audit Risk | 10 |
| Average Daily Volume10 Day | 126,860 |
| Average Daily Volume3 Month | 3,890,392 |
| Average Volume | 3,890,392 |
| Average Volume10Days | 126,860 |
| Beta | 0.775 |
| Bid | 1.29 |
| Bid Size | 2 |
| Board Risk | 10 |
| Book Value | -1.208 |
| City | Florham Park |
| Compensation As Of Epoch Date | 1,735,603,200 |
| Compensation Risk | 7 |
| Country | United States |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 1.42 |
| Current Ratio | 0.089 |
| Custom Price Alert Confidence | HIGH |
| Date Short Interest | 1,790,726,400 |
| Day High | 1.55 |
| Day Low | 1.4 |
| Display Name | Celularity |
| Dividend Yield | 0.0 |
| Earnings Timestamp End | 1,755,547,200 |
| Earnings Timestamp Start | 1,755,547,200 |
| Ebitda | -53,897,000 |
| Ebitda Margins | -2.84117 |
| Enterprise To Ebitda | -2.111 |
| Enterprise To Revenue | 5.998 |
| Enterprise Value | 113,790,672 |
| Eps Forward | -0.57 |
| Eps Trailing Twelve Months | -2.73 |
| Esg Populated | 0 |
| Exchange | NCM |
| Exchange Data Delayed By | 15 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fifty Day Average | 1.21836 |
| Fifty Day Average Change | 0.20164001 |
| Fifty Day Average Change Percent | 0.16550118 |
| Fifty Two Week Change Percent | -35.24229 |
| Fifty Two Week High | 2.55 |
| Fifty Two Week High Change | -1.13 |
| Fifty Two Week High Change Percent | -0.44313726 |
| Fifty Two Week Low | 0.56 |
| Fifty Two Week Low Change | 0.85999995 |
| Fifty Two Week Low Change Percent | 1.5357141 |
| Fifty Two Week Range | 0.56 - 2.55 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 1,565,271,000,000 |
| Float Shares | 22,372,816 |
| Forward Eps | -0.57 |
| Forward P E | -2.491228 |
| Free Cashflow | -1,360,625 |
| Full Exchange Name | NasdaqCM |
| Full Time Employees | 115 |
| Fullday Change | -0.05000007 |
| Fullday Change Percent | -3.4013653 |
| Fullday Price | 1.42 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Governance Epoch Date | 1,790,812,800 |
| Gross Margins | 0.052610002 |
| Gross Profits | 998,000 |
| Has Pre Post Market Data | 1 |
| Held Percent Insiders | 0.33167 |
| Held Percent Institutions | 0.11428001 |
| Implied Shares Outstanding | 32,449,767 |
| Industry | Biotechnology |
| Industry Disp | Biotechnology |
| Industry Key | biotechnology |
| Is Earnings Date Estimate | 1 |
| Language | en-US |
| Last Fiscal Year End | 1,767,139,200 |
| Last Split Date | 1,709,164,800 |
| Last Split Factor | 1:10 |
| Long Business Summary | Celularity Inc., a cellular and regenerative medicine company, focuses on addressing aging-related disease using novel therapies. The company operates through three segments: Cell Therapy, Degenerative Disease, and BioBanking. It develops off-the-shelf placental-derived allogeneic cell therapy product candidates, including mesenchymal-like adherent stromal cells for diabetic foot ulcer and Crohn's disease. Its therapeutic programs include PDA-001 for the treatment of autoimmune (Crohn's) and degenerative disease; and PDA-002 for treating multiple sclerosis, rheumatoid arthritis, stroke, and diabetic peripheral neuropathy. The company also produces, sells, and licenses products used in surgical and wound care markets, such as Biovance, Biovance 3L, Rebound, Interfyl, and Centaflex; and collects, processes, and stores umbilical cord and placental blood and tissue after full-term pregnancies under the LifebankUSA brand. Celularity Inc. has licensing agreement with Sorrento Therapeutics, Inc. for the development and commercialization of licensed CD19 CAR-T products; and research collaboration services agreement with Regeneron Pharmaceuticals, Inc. to support the research of allogeneic cell therapy candidates. Celularity Inc. was founded in 1998 and is headquartered in Florham Park, New Jersey. |
| Long Name | Celularity Inc. |
| Market | us_market |
| Market Cap | 46,078,668 |
| Market State | PREPRE |
| Max Age | 86,400 |
| Message Board Id | finmb_408304689 |
| Most Recent Quarter | 1,774,915,200 |
| Name Change Date | 2,026-10-14 |
| Net Income To Common | -71,307,000 |
| Next Fiscal Year End | 1,798,675,200 |
| Non Diluted Market Cap | 33,577,314 |
| Open | 1.45 |
| Operating Cashflow | -8,814,000 |
| Operating Margins | -2.63469 |
| Overall Risk | 10 |
| Payout Ratio | 0.0 |
| Phone | 908 768 2170 |
| Prev Name | GX Acquisition Corp. |
| Previous Close | 1.47 |
| Price Hint | 4 |
| Price To Book | -1.1754967 |
| Price To Sales Trailing12 Months | 2.4290283 |
| Profit Margins | 0.0 |
| Quick Ratio | 0.073 |
| Quote Source Name | Delayed Quote |
| Quote Type | EQUITY |
| Recommendation Key | none |
| Region | US |
| Regular Market Change | -0.0500001 |
| Regular Market Change Percent | -3.40137 |
| Regular Market Day High | 1.55 |
| Regular Market Day Low | 1.4 |
| Regular Market Day Range | 1.4 - 1.55 |
| Regular Market Open | 1.45 |
| Regular Market Previous Close | 1.47 |
| Regular Market Price | 1.42 |
| Regular Market Time | 1,791,921,601 |
| Regular Market Volume | 50,310 |
| Return On Assets | -0.3232 |
| Revenue Growth | -0.663 |
| Revenue Per Share | 0.703 |
| Sand P52 Week Change | 0.17502642 |
| Sector | Healthcare |
| Sector Disp | Healthcare |
| Sector Key | healthcare |
| Share Holder Rights Risk | 7 |
| Shares Outstanding | 32,449,767 |
| Shares Percent Shares Out | 0.0121 |
| Shares Short | 391,276 |
| Shares Short Previous Month Date | 1,788,134,400 |
| Shares Short Prior Month | 1,897,722 |
| Short Name | Celularity Inc. |
| Short Percent Of Float | 0.0385 |
| Short Ratio | 0.94 |
| Source Interval | 15 |
| State | NJ |
| Symbol | CELU |
| Total Cash | 368,000 |
| Total Cash Per Share | 0.011 |
| Total Debt | 68,080,000 |
| Total Revenue | 18,970,000 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Eps | -2.73 |
| Trailing Peg Ratio | None |
| Triggerable | 1 |
| Two Hundred Day Average | 1.09952 |
| Two Hundred Day Average Change | 0.32048 |
| Two Hundred Day Average Change Percent | 0.29147264 |
| Type Disp | Equity |
| Volume | 50,310 |
| Website | https://www.celularity.com |
| Zip | 7,932 |